In human macrophages containing the INAVA rs7554511 IBD-risk allele (low-INAVA expressing carriers), wild type INAVA expression enhances, and ARNO expression suppresses IL-1β and NOD2 signaling. This evidence concerns the gene CYTH2 and inflammatory bowel disease.